163 related articles for article (PubMed ID: 25270731)
21. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
22. [Construction of recombinant eukaryotic expression plasmid containing 1.3-fold-overlength genome of HBV and its expression in HepG2 cells].
Tang N; Huang AL; Zhang BQ; Yan G; Xiang MQ; Pu D; Guo H
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):464-6. PubMed ID: 12939176
[TBL] [Abstract][Full Text] [Related]
23. Defective DNA damage response and repair in liver cells expressing hepatitis B virus surface antigen.
Chung YL
FASEB J; 2013 Jun; 27(6):2316-27. PubMed ID: 23444429
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
25. Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface.
Yang J; Wang F; Tian L; Su J; Zhu X; Lin L; Ding X; Wang X; Wang S
Arch Virol; 2010 Jun; 155(6):881-8. PubMed ID: 20364278
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
Huang KL; Lai YK; Lin CC; Chang JM
World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029
[TBL] [Abstract][Full Text] [Related]
27. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus upregulates host expression of α-1,2-mannosidases
Hu S; Jiang LB; Zou XJ; Yi W; Tian DY
World J Gastroenterol; 2016 Nov; 22(43):9534-9543. PubMed ID: 27920474
[TBL] [Abstract][Full Text] [Related]
29. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.
Song J; Zhang X; Ge Q; Yuan C; Chu L; Liang HF; Liao Z; Liu Q; Zhang Z; Zhang B
J Cell Biochem; 2018 Nov; 119(10):8419-8431. PubMed ID: 29904948
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
Gao YF; Yu L; Wei W; Li JB; Luo QL; Shen JL
World J Gastroenterol; 2008 Aug; 14(29):4684-9. PubMed ID: 18698684
[TBL] [Abstract][Full Text] [Related]
32. [Roles of full-length and truncated hepatitis B virus X protein and of interactions with the host-encoded damaged DNA binding protein 1 in HBV replication].
Yang X; He S; Luo N; Luo L; Fan H; Gong Q
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):446-51. PubMed ID: 24034847
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus promotes autophagic degradation but not replication in autophagosome.
Yang H; Fu Q; Liu C; Li T; Wang Y; Zhang H; Lu X; Sang X; Zhong S; Huang J; Mao Y
Biosci Trends; 2015 Apr; 9(2):111-6. PubMed ID: 25971696
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells.
Wu J; Zhang XJ; Shi KQ; Chen YP; Ren YF; Song YJ; Li G; Xue YF; Fang YX; Deng ZJ; Xu X; Gao J; Tang KF
Carcinogenesis; 2014 Jan; 35(1):155-63. PubMed ID: 23917076
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.
Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T
Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844
[TBL] [Abstract][Full Text] [Related]
37. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH
Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
[TBL] [Abstract][Full Text] [Related]
38. Targeted inhibition of hepatitis B virus gene expression: a gene therapy approach.
Tung FY; Bowen SW
Front Biosci; 1998 Feb; 3():a11-5. PubMed ID: 9450988
[TBL] [Abstract][Full Text] [Related]
39. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15.
Yao Y; Li J; Lu Z; Tong A; Wang W; Su X; Zhou Y; Mu B; Zhou S; Li X; Chen L; Gou L; Song H; Yang J; Wei Y
Electrophoresis; 2011 Aug; 32(15):2004-12. PubMed ID: 21739463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
